Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis

Research output: Contribution to journal › Article › peer-review

657 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology